R. Ghisini

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

Viviana Galimberti, Bernard F. Cole, Giuseppe Viale et al. · The Lancet Oncology · 2018 · 533 citations

Surgical Oncology, Breast Oncology, Medicine +7

Clinical Relevance of <i>HER2</i> Overexpression/Amplification in Patients With Small Tumor Size and Node-Negative Breast Cancer

Giuseppe Curigliano, Giuseppe Viale, Vincenzo Bagnardi et al. · Journal of Clinical Oncology · 2009 · 255 citations · Full text

Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (&lt;35 years) with operable breast cancer

Giuseppe Cancello, Patrick Maisonneuve, Nicole Rotmensz et al. · Annals of Oncology · 2010 · 236 citations · Full text

Surgical Oncology, Oncology, Adjuvant Treatment Effects +8

Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor activity and biological effects

Marco Colleoni, Laura Orlando, Giuseppina Sanna et al. · Annals of Oncology · 2005 · 187 citations · Full text

Metastatic Breast Cancer, Antitumor Activity, Biological Effects +12

Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer

Laura Orlando, Anna Cardillo, R. Ghisini et al. · BMC Cancer · 2006 · 120 citations · Full text